Relmada Therapeutics (RLMD) Selling, General & Administrative (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 1.32 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -37.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.17 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 493.70 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -1.52 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 647.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 322.55 Mn
10 Relmada Therapeutics 595.35 Mn 595.35 Mn - 11.37 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.37 Mn
Dec 31, 2025 12.26 Mn
Sep 30, 2025 6.29 Mn
Jun 30, 2025 7.40 Mn
Mar 31, 2025 6.27 Mn
Dec 31, 2024 8.08 Mn
Sep 30, 2024 11.86 Mn
Jun 30, 2024 8.10 Mn
Mar 31, 2024 9.68 Mn
Dec 31, 2023 12.08 Mn
Sep 30, 2023 12.24 Mn
Jun 30, 2023 12.29 Mn
Mar 31, 2023 12.29 Mn
Dec 31, 2022 11.83 Mn
Sep 30, 2022 8.21 Mn
Jun 30, 2022 14.60 Mn
Mar 31, 2022 13.28 Mn
Dec 31, 2021 8.91 Mn
Sep 30, 2021 8.66 Mn
Jun 30, 2021 9.13 Mn
Mar 31, 2021 8.38 Mn
Dec 31, 2020 6.02 Mn
Sep 30, 2020 5.95 Mn
Jun 30, 2020 7.43 Mn
Mar 31, 2020 5.47 Mn
Dec 31, 2019 4.76 Mn
Sep 30, 2019 1.82 Mn
Jun 30, 2019 1.07 Mn
Mar 31, 2019 1.43 Mn
Dec 31, 2018 2.22 Mn
Sep 30, 2018 989,748.00
Mar 31, 2018 883,009.00
Dec 31, 2017 1.31 Mn
Sep 30, 2017 815,106.00
Jun 30, 2017 1.60 Mn
Mar 31, 2017 1.79 Mn
Dec 31, 2016 1.28 Mn
Sep 30, 2016 1.25 Mn
Jun 30, 2016 2.49 Mn
Mar 31, 2016 2.14 Mn
Dec 31, 2015 3.60 Mn
Sep 30, 2015 1.76 Mn
Jun 30, 2015 1.54 Mn
Mar 31, 2015 2.30 Mn
Dec 31, 2014 2.29 Mn
Sep 30, 2014 3.00 Mn
Jun 30, 2014 12.11 Mn
Mar 31, 2014 -496,103.00
Nov 30, 2013 14,538.00
May 31, 2013 19,797.00
Feb 28, 2013 3,905.00
Nov 30, 2012 9,010.00
Aug 31, 2012 8,098.00
May 31, 2012 2,589.00